LABP – landos biopharma, inc. (US:NASDAQ)
Stock Stats
News
AbbVie (ABBV) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie
SHAREHOLDER ALERT: Weiss Law Investigates Landos Biopharma, Inc.
Landos Biopharma, Inc. (NASDAQ: LABP) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $20.42 price target on the stock, down previously from $50.00.
LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP
Form DEFM14A Landos Biopharma, Inc.
Form 10-K/A Landos Biopharma, Inc. For: Dec 31
Form PREM14A Landos Biopharma, Inc. For: Apr 15
Form SC 13D/A Landos Biopharma, Inc. Filed by: PERCEPTIVE ADVISORS LLC
Form SC 13D/A Landos Biopharma, Inc. Filed by: Xontogeny, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.